Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.
过氧化物酶体增殖激活受体γ激动剂治疗可增加新生儿慢性肺疾病实验模型中的间隔形成和血管生成，并降低气道高反应性
期刊:Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
影响因子:2.1
doi:10.1002/ar.20921
Takeda K, Okamoto M, de Langhe S, Dill E, Armstrong M, Reisdorf N, Irwin D, Koster M, Wilder J, Stenmark K R, West J, Klemm D, Gelfand E W, Nozik-Grayck E, Majka S M
